Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Groups

Publications

  • Jove, M; Gatius, S; Yeramian, A; Portero-Otin, M; Eritja, N; Santacana, M; Colas, E; Ruiz, M; Pamplona, R; Matias-Guiu, X

    Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism

    Oncotarget 7 52364-52374. .

    [doi:10.18632/oncotarget.10564]

  • Hellner, K; Miranda, F; Fotso Chedom D; Herrero-Gonzalez, S; Hayden, DM; Tearle, R; Artibani, M; KaramiNejadRanjbar, M; Williams R; Gaitskell, K; Elorbany, S; Xu, RY; Laios, A; Buiga, P; Ahmed, K; Dhar, S; Zhang, RY; Campo, L; Myers, KA; Lozano, M; Ruiz-Miro, M; Gatius, S; Mota, A; Moreno-Bueno, G; Matias-Guiu, X; Benitez, J; Witty, L; McVean, G; Leedham, S; Tomlinson, I; Drmanac, R; Cazier, JB; Klein, R; Dunne, K; Bast, RC; Kennedy, SH; Hassan, B; Lise, S; Garcia, MJ; Peters, BA; Yau, C; Sauka-Spengler, T; Ahmed, AA

    Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies

    EBioMedicine 10 137-149. .

    [doi:10.1016/j.ebiom.2016.06.048]

  • Mirantes, C; Dosil, MA; Eritja, N; Felip, I; Gatius, S; Santacana, M; Matias-Guiu, X; Dolcet, X

    Effects of the multikinase inhibitors Sorafenib and Regorafenib in PTEN deficient neoplasias

    EUROPEAN JOURNAL OF CANCER 63 74-87. .

    [doi:10.1016/j.ejca.2016.04.019]

  • Yeramian A; García V; Bergadà L; Domingo M; Santacana M; Valls J; Martinez-Alonso M; Carceller JA; Cussac AL; Dolcet X; Matias-Guiu X

    Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-kappa B Pathway in Endometrial Cancer

    MOLECULAR IMAGING AND BIOLOGY 18 545-556. .

    [doi:10.1007/s11307-015-0907-8]

  • Campoy, I; Lanau, L; Altadill, T; Sequeiros, T; Cabrera, S; Cubo-Abert, M; Perez-Benavente, A; Garcia, A; Borros, S; Santamaria, A; Ponce, J; Matias-Guiu, X; Reventos, J; Gil-Moreno, A; Rigau, M; Colas, E

    Exosome-like vesicles in uterine aspirates: a comparison of ultracentrifugation-based isolation protocols

    Journal Of Translational Medicine 14 180-180. .

    [doi:10.1186/s12967-016-0935-4]

  • Santacana M; Coronado P; Matias-Guiu X; Romero I; Casado A; Gil-Moreno A; Dosil MA; Mota A; Moreno-Bueno G; Dolcet X; Llombart-Cussac A; Poveda A

    Biological Effects of Temsirolimus on the mTOR Pathway in Endometrial Carcinoma: A Pharmacodynamic Phase II Study.

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER -. .

    [doi:10.1097/IGC.0000000000000715]

  • Schultheis, AM; Ng, CKY; De Filippo, MR; Piscuoglio, S; Macedo, GS; Gatius, S; Perez Mies B; Soslow, RA; Lim, RS; Viale, A; Huberman, KH; Palacios, JC; Reis-Filho, JS; Matias-Guiu, X; Weigelt, B

    Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas

    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 108 -. .

    [doi:10.1093/jnci/djv427]

  • Fuste, NP; Castelblanco, E; Felip, I; Santacana, M; Fernandez-Hernandez, R; Gatius, S; Pedraza, N; Pallares, J; Cemeli, T; Valls, J; Tarres, M; Ferrezuelo, F; Dolcet, X; Matias-Guiu, X; Gari, E

    Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer

    Oncotarget 7 26979-26991. .

    [doi:10.18632/oncotarget.8876]

  • Yeramian, A; Vea, A; Benitez, S; Ribera, J; Domingo, M; Santacana, M; Martinez, M; Maiques, O; Valls, J; Dolcet, X; Vilella, R; Cabiscol, E; Matias-Guiu, X; Marti, RM

    2-phenylethynesulphonamide (PFT-) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels

    PIGMENT CELL & MELANOMA RESEARCH 29 352-371. .

    [doi:10.1111/pcmr.12472]

  • Mirantes, C; Dosil, MA; Hills, D; Yang, J; Eritja, N; Santacana, M; Gatius, S; Vilardell, F; Medvinsky, A; Matias-Guiu, X; Dolcet, X

    Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies

    Blood 127 1907-1911. .

    [doi:10.1182/blood-2015-09-669036]

  • Eritja, N; Arjo, G; Santacana, M; Gatius, S; Ramirez-Nunez, O; Arcal, L; Serrano, JCE; Pamplona, R; Dolcet, X; Pinol, C; Christou, P; Matias-Guiu, X; Portero-Otin, M

    Oral intake of genetically engineered high-carotenoid corn ameliorates hepatomegaly and hepatic steatosis in PTEN haploinsufficient mice

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1862 526-535. .

    [doi:10.1016/j.bbadis.2016.01.018]

  • Vaquero, M; Macia, A; Anerillas, C; Velasco, A; Matias-Guiu, X; Ribera, J; Encinas, M

    Sprouty1 haploinsufficiency accelerates pheochromocytoma development in Pten(+/-) mice

    ENDOCRINE-RELATED CANCER 23 7-11. .

    [doi:10.1530/ERC-15-0585]

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment